Timolol maleate gel - Auson Pharmaceuticals
Alternative Names: ASN-001 - Auson Pharmaceuticals; Timolol MaleateLatest Information Update: 13 Feb 2025
At a glance
- Originator Auson Pharmaceuticals
- Class Antineoplastics
- Mechanism of Action Beta adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II/III Haemangioma
Most Recent Events
- 21 Jun 2022 Auson Pharmaceuticals completes phase-II/III clinical trials in Haemangioma (In infants) in China (Topical) (NCT06677853)
- 28 Oct 2020 Phase-II/III clinical trials in Haemangioma (In infants) in China (Topical) (NCT06677853)
- 28 Oct 2020 Auson Pharmaceuticals completes phase-I clinical trials in Haemangioma (Topical) prior to October 2020 (Auson Pharmaceuticals pipeline, November 2024)